MENU
+Compare
CLBT
Stock ticker: NASDAQ
AS OF
Jun 10, 03:16 PM (EDT)
Price
$16.21
Change
-$0.41 (-2.47%)
Capitalization
2.27B

CLBT Cellebrite DI Ltd Forecast, Technical & Fundamental Analysis

Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data... Show more

CLBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLBT with price predictions
Jun 09, 2025

CLBT sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CLBT moved below the 200-day moving average on May 08, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CLBT as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CLBT moved below its 50-day moving average on May 14, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CLBT crossed bearishly below the 50-day moving average on May 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CLBT entered a downward trend on June 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLBT's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where CLBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CLBT just turned positive on June 09, 2025. Looking at past instances where CLBT's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLBT advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CLBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (66.225) is normal, around the industry mean (31.685). P/E Ratio (67.114) is within average values for comparable stocks, (163.514). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.724). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (6.435) is also within normal values, averaging (61.551).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
CLBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLBT is expected to report earnings to fall 6.57% to 6 cents per share on August 06

Cellebrite DI Ltd CLBT Stock Earnings Reports
Q2'25
Est.
$0.07
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.06
The last earnings report on May 14 showed earnings per share of 7 cents, beating the estimate of 4 cents. With 441.15K shares outstanding, the current market capitalization sits at 2.27B.
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
N/A
Address
94 Shlomo Shmelzer Road
Phone
+972 733948000
Employees
1008
Web
https://www.cellebrite.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDMIX14.63N/A
N/A
Lazard Developing Markets Equity Instl
BAFSX44.44N/A
N/A
Brown Advisory Small-Cap Growth Inst
LRSSX14.16N/A
N/A
Lord Abbett Small Cap Value R4
BGEFX14.25N/A
-0.03%
Baillie Gifford International Growth 4
MVRRX49.72-0.08
-0.16%
MFS Value R2

CLBT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLBT has been loosely correlated with PEGA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CLBT jumps, then PEGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLBT
1D Price
Change %
CLBT100%
+0.54%
PEGA - CLBT
49%
Loosely correlated
-0.41%
DDOG - CLBT
47%
Loosely correlated
-0.81%
TTD - CLBT
45%
Loosely correlated
+0.04%
KVYO - CLBT
44%
Loosely correlated
+2.06%
SPT - CLBT
43%
Loosely correlated
+0.74%
More